Genital Inflammatory Responses in Women Living with HIV Randomized to Copper or Levonorgestrel Intrauterine Contraceptives: A secondary analysis of a randomized trial
In a secondary analysis of a randomized trial involving women living with HIV, the study found that while the copper intrauterine device (C IUC) induced broad and sustained increases in cervicovaginal cytokines among women on antiretroviral therapy, the levonorgestrel intrauterine system (LNG IUS) caused minimal inflammatory changes, suggesting LNG IUS is a less inflammatory contraceptive option for this population.